Lauren Davey

Has grant

Assistant Professor

City Of Hope National Medical Center
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

Modulation of the intestinal bacterium Akkermansia muciniphila to enhance healthy aging and longevity

Open Date: 2024-10-01

Close Date: 2027-09-30

Grant: Open

Mucus-degrading intestinal bacteria and toxicities of hematopoietic cell transplantation

Open Date: 2024-09-21

Close Date: 2029-07-31

Grant: Close

Genetic Dissection of Nutrient Acquisition in Diverse Akkermansia Strains

Open Date: 2022-04-01

Close Date: 2023-03-31

Grant: Close

Investigation of disulfide bond formation in Streptococcus pyogenes

Open Date: 2018-04-01

Close Date: 2019-03-31

Grant: Close

Effect of Pseudomonas aeruginosa elastase on Listeria biofilms

Open Date: 2010-04-01

Close Date: 2011-03-31

Articles (11)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Akkermansia muciniphila , an obligate mucin degrader, is a major member of the human colonic microbiota and has been associated positive health outcomes. Mucins are complex glycoproteins that contain heavily sulfated O -glycans and form the protective colonic mucus layer. Bacterial carbohydrate sulfatases are required to metabolise these heavily sulfated mucin glycans and excessive bacterial foraging has been associated with several diseases. Sulfatases have been linked with inflammatory bowel disease, making these microbiota enzymes potential drug targets. A. muciniphila expresses carbohydrate sulfatases that can act on colonic mucins yet their roles in its metabolism remain opaque. Our data reveal that A. muciniphila requires glycopeptides/protein forms of colonic mucin for metabolism and its sulfatases have unique adaptations compared to Bacteroides species. Localisation studies reveal that desulfation of N -acetyl-D-glucosamine, but not D-galactose, is exclusively periplasmic. A cell surface sulfatase has a novel carbohydrate binding module that binds to colonic mucin. This paints a contrasting picture of sulfated mucin metabolism by Akkermansia muciniphila versus Bacteroides species. These data will be important for understanding the contexts for Akkermansia muciniphila ’s positive health correlations.

Year:

2025

Aim: Akkermansia are common members of the human gastrointestinal microbiota. The prevalence of these mucophilic bacteria, especially Akkermansia muciniphila (A. muciniphila ), correlates with immunological and metabolic health. The genus Akkermansia in humans includes species with significantly larger genomes than A. muciniphila , leading us to postulate that this added genetic content may influence how they impact human metabolic and immunological health. Methods: We conducted a pangenomic analysis of 234 Akkermansia complete or near-complete genomes. We also used high-resolution species and subspecies assignments to reanalyze publicly available metagenomic datasets to determine if there are relationships between Akkermansia species and A. muciniphila clades with various disease outcomes. Results: Analysis of genome-wide average nucleotide identity, 16S rRNA gene identity, conservation of core Akkermansia genes, and analysis of the fatty acid composition of representative isolates support the partitioning of the genus Akkermansia into several species. In addition, A. muciniphila sensu stricto , the most prevalent Akkermansia species in humans, should be subdivided into two subspecies. For a pediatric cohort, we observed species-specific correlations between Akkermansia abundance with baseline obesity or after various interventions. For inflammatory bowel disease cohorts, we identified a decreased abundance of Akkermansia in patients with ulcerative colitis or Crohn’s disease, which was species and subspecies-dependent. In patients undergoing immune checkpoint inhibitor therapies for non-small cell lung carcinoma, we observed a significant association between one A. muciniphila subspecies and survival outcomes. Conclusion: Our findings suggest that the prevalence of specific Akkermansia species and/or subspecies can be crucial in evaluating their association with human health, particularly in different disease contexts, and is an important consideration for their use as probiotics.

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (11)

Alan Cartmell

Senior Lecturer

University of Liverpool

UNITED KINGDOM
View details

Helena Petrosova

Assistant Professor

University of Victoria

CANADA
View details

Sjoerd van der Post

Göteborgs Universitet

SWEDEN
View details

Daniel J. Rigden

Personal Chair

University of Liverpool

UNITED KINGDOM
View details

Debajit Dey

University of Leeds

UNITED KINGDOM
View details

David Robinson Goodlett

Professor and Proteome Centre Director

University of Victoria

CANADA
View details

Lawrence David

Assistant Professor

Duke University School of Medicine

UNITED STATES
View details

E. A. Yates

Reader

University of Liverpool

UNITED KINGDOM
View details

Gang Fang

Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES
View details

Christoph George Baumann

Lecturer in Molecular Biophysics

University of York

UNITED KINGDOM
View details

Maria Emilia Panzetta

Research Associate Sr

Duke University

UNITED STATES
View details